Helen Williams
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Helen Williams has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Jason Lee Johnson
Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol Royal infirmary, Bristol BS2 8HW, UK
4 shared publications - Sarah Jane George
Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol Royal infirmary, Bristol BS2 8HW, UK
4 shared publications - Akkam Sandeep
Department of Postgraduate Research in Clinical Pharmacy Santhiram College of Pharmacy India
1 shared publication - Aleksandra Frankow
Translational Health Sciences, Bristol Medical School, Bristol, UK
1 shared publication Alexandros Somos
Univ Bristol, Bristol Heart Inst, Bristol Med Sch, Bristol, England
1 shared publicationAndrew Bond
Univ Bristol, Bristol Heart Inst, Bristol Med Sch, Bristol, England
1 shared publication
Latest Publications
- Open Access
- 22 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10274
Augmented Flow-Induced Outward Remodelling Occurs with Ageing in Mice
Outward remodelling of arteries is a feature of cardiovascular pathologies such as atherosclerosis and aneurysm, so a greater understanding of the processes involved in remodelling may aid the development of improved therapies for patients. As ageing increases the risk of atherosclerosis and aneurysmal disease, it was therefore hypothesised that ageing affects arterial remodelling and thereby contributes to these diseases. To test this hypothesis, we compared right carotid artery remodelling in young (2 months, n = 13) and old (18–20 months, n = 13) mice resulting from increased blood flow after ligation of the left carotid artery. The media area, thickness, collagen content and α-SM-actin content per cell of control right carotid arteries from old mice were significantly greater than observed in young mice. Positive remodelling was observed in the carotid arteries of both old and young mice 21 days after ligation of the left carotid artery. However, arteries from old mice had a significantly larger increase in lumen size and reduction in media area, thickness and α-SM-actin content per cell compared to young arteries, indicative of augmented positive remodelling in arteries from old mice. Remodelling was associated with significantly increased MMP-2 protein in arteries from young mice, but this was not observed in arteries from old mice. This study demonstrates that the extent of positive remodelling of carotid arteries is greater in old mice than in young mice and results in a potentially less resilient medial layer with decreased α-SM-actin content per cell, elastin and collagen that may promote atherosclerosis and aneurysm formation.
- 22 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10274
Open AccessAugmented Flow-Induced Outward Remodelling Occurs with Ageing in Mice
Outward remodelling of arteries is a feature of cardiovascular pathologies such as atherosclerosis and aneurysm, so a greater understanding of the processes involved in remodelling may aid the development of improved therapies for patients. As ageing increases the risk of atherosclerosis and aneurysmal disease, it was therefore hypothesised that ageing affects arterial remodelling and thereby contributes to these diseases. To test this hypothesis, we compared right carotid artery remodelling in young (2 months, n = 13) and old (18–20 months, n = 13) mice resulting from increased blood flow after ligation of the left carotid artery. The media area, thickness, collagen content and α-SM-actin content per cell of control right carotid arteries from old mice were significantly greater than observed in young mice. Positive remodelling was observed in the carotid arteries of both old and young mice 21 days after ligation of the left carotid artery. However, arteries from old mice had a significantly larger increase in lumen size and reduction in media area, thickness and α-SM-actin content per cell compared to young arteries, indicative of augmented positive remodelling in arteries from old mice. Remodelling was associated with significantly increased MMP-2 protein in arteries from young mice, but this was not observed in arteries from old mice. This study demonstrates that the extent of positive remodelling of carotid arteries is greater in old mice than in young mice and results in a potentially less resilient medial layer with decreased α-SM-actin content per cell, elastin and collagen that may promote atherosclerosis and aneurysm formation.
- Open Access
- 1 September 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (3) , 605-613
A cross-sectional study of psychosocial variables associated with medication burden among type 2 diabetes mellitus with multiple comorbidities in geriatric patients
Introduction and aim. As the population ages, the management of type 2 diabetes mellitus in older adults with multiple comorbidities becomes more complex. Geriatric patients often face a medication burden, impacting their quality of life and adherence. Psychosocial variables such as depression, anxiety, social support, and health literacy may influence how patients cope with their medications. This study explores the relationship between these variables and the burden in geriatric patients with type 2 diabetes and comorbidities, offering insight into improving care and outcomes. Material and methods. The cross-sectional survey was carried out from April to September 2024. 250 patients were included. The demographics of the participants, the burden of the disease, polypharmacy, the burden of the medication, and the psychosocial variables were evaluated. Univariate and multivariate linear regression analyzes assessed the variables associated with the burden of medications. Results. There was a positive correlation between the belief in medication, depression, disease burden, number of medications, number of comorbidities, and medication burden (p0.05). Conclusion. Low self-efficacy, depression, polypharmacy, high disease burden, and decreased medication satisfaction can all contribute to medication burden. Comprehending these factors helps identify patients with geriatric diabetes and enables personalized treatment to ease their burden.
- 1 September 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (3) , 605-613
Open AccessA cross-sectional study of psychosocial variables associated with medication burden among type 2 diabetes mellitus with multiple comorbidities in geriatric patients
Introduction and aim. As the population ages, the management of type 2 diabetes mellitus in older adults with multiple comorbidities becomes more complex. Geriatric patients often face a medication burden, impacting their quality of life and adherence. Psychosocial variables such as depression, anxiety, social support, and health literacy may influence how patients cope with their medications. This study explores the relationship between these variables and the burden in geriatric patients with type 2 diabetes and comorbidities, offering insight into improving care and outcomes. Material and methods. The cross-sectional survey was carried out from April to September 2024. 250 patients were included. The demographics of the participants, the burden of the disease, polypharmacy, the burden of the medication, and the psychosocial variables were evaluated. Univariate and multivariate linear regression analyzes assessed the variables associated with the burden of medications. Results. There was a positive correlation between the belief in medication, depression, disease burden, number of medications, number of comorbidities, and medication burden (p0.05). Conclusion. Low self-efficacy, depression, polypharmacy, high disease burden, and decreased medication satisfaction can all contribute to medication burden. Comprehending these factors helps identify patients with geriatric diabetes and enables personalized treatment to ease their burden.
- Open Access
- 30 September 2024
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 22 (3) , 498-506
A cross-sectional study on knowledge, attitude, and practice among type 2 diabetes mellitus patients attending a primary health care center in the rural region of Tamil Nadu
Introduction and aim. Diabetes mellitus (DM) is a basic metabolic disease of inadequate control of blood glucose levels. Hyperglycemia is exacerbated, and type 2 diabetes mellitus (T2DM) progresses both insulin resistance and β-cell dysfunction. Management of T2DM involves both lifestyle modification and pharmacological therapy. To achieve optimized health outcomes, the patient requires adequate knowledge, attitude, and practice, so educating the patients on these diseases is an effective strategy to reduce complications of T2DM. Material and methods. This is a cross-sectional study which was conducted from August 2022 to January 2023. A total of 200 participants were enrolled with inclusion criteria to determine the knowledge, attitude, and practice of type 2 diabetes mellitus patients. Results. The mean knowledge, attitude and practice (KAP) was 71.5%, 87.5%, and 40% respectively. There is a significant association between knowledge, attitude, practice questions, and socio-demographic characteristics. Education was strongly associated with having higher knowledge scores (p=0.001). Conclusion. The study’s conclusions made clear the necessity of well-planned interventions to raise T2DM awareness among patients with low levels of education. Patients with T2DM may benefit from well-designed educational programs that encourage healthy behavior and these interventions can improve the quality of life of patients in rural region of Tamil Nadu.
- 30 September 2024
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 22 (3) , 498-506
Open AccessA cross-sectional study on knowledge, attitude, and practice among type 2 diabetes mellitus patients attending a primary health care center in the rural region of Tamil Nadu
Introduction and aim. Diabetes mellitus (DM) is a basic metabolic disease of inadequate control of blood glucose levels. Hyperglycemia is exacerbated, and type 2 diabetes mellitus (T2DM) progresses both insulin resistance and β-cell dysfunction. Management of T2DM involves both lifestyle modification and pharmacological therapy. To achieve optimized health outcomes, the patient requires adequate knowledge, attitude, and practice, so educating the patients on these diseases is an effective strategy to reduce complications of T2DM. Material and methods. This is a cross-sectional study which was conducted from August 2022 to January 2023. A total of 200 participants were enrolled with inclusion criteria to determine the knowledge, attitude, and practice of type 2 diabetes mellitus patients. Results. The mean knowledge, attitude and practice (KAP) was 71.5%, 87.5%, and 40% respectively. There is a significant association between knowledge, attitude, practice questions, and socio-demographic characteristics. Education was strongly associated with having higher knowledge scores (p=0.001). Conclusion. The study’s conclusions made clear the necessity of well-planned interventions to raise T2DM awareness among patients with low levels of education. Patients with T2DM may benefit from well-designed educational programs that encourage healthy behavior and these interventions can improve the quality of life of patients in rural region of Tamil Nadu.
- Open Access
- 26 August 2024
- Published by Elsevier in Atherosclerosis
- Vol. 397, 118570
CCN4 (WISP-1) reduces apoptosis and atherosclerotic plaque burden in an ApoE mouse model
- 26 August 2024
- Published by Elsevier in Atherosclerosis
- Vol. 397, 118570
Open AccessCCN4 (WISP-1) reduces apoptosis and atherosclerotic plaque burden in an ApoE mouse model
- Open Access
WISP-1 Regulates Cardiac Fibrosis by Promoting Cardiac Fibroblasts’ Activation and Collagen Processing
Hypertension induces cardiac fibrotic remodelling characterised by the phenotypic switching of cardiac fibroblasts (CFs) and collagen deposition. We tested the hypothesis that Wnt1-inducible signalling pathway protein-1 (WISP-1) promotes CFs’ phenotypic switch, type I collagen synthesis, and in vivo fibrotic remodelling. The treatment of human CFs (HCFs, n = 16) with WISP-1 (500 ng/mL) induced a phenotypic switch (α-smooth muscle actin-positive) and type I procollagen cleavage to an intermediate form of collagen (pC-collagen) in conditioned media after 24h, facilitating collagen maturation. WISP-1-induced collagen processing was mediated by Akt phosphorylation via integrin β1, and disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAMTS-2). WISP-1 wild-type (WISP-1+/+) mice and WISP-1 knockout (WISP-1−/−) mice (n = 5–7) were subcutaneously infused with angiotensin II (AngII, 1000 ng/kg/min) for 28 days. Immunohistochemistry revealed the deletion of WISP-1 attenuated type I collagen deposition in the coronary artery perivascular area compared to WISP-1+/+ mice after a 28-day AngII infusion, and therefore, the deletion of WISP-1 attenuated AngII-induced cardiac fibrosis in vivo. Collectively, our findings demonstrated WISP-1 is a critical mediator in cardiac fibrotic remodelling, by promoting CFs’ activation via the integrin β1-Akt signalling pathway, and induced collagen processing and maturation via ADAMTS-2. Thereby, the modulation of WISP-1 levels could provide potential therapeutic targets in clinical treatment.
Open AccessWISP-1 Regulates Cardiac Fibrosis by Promoting Cardiac Fibroblasts’ Activation and Collagen Processing
Hypertension induces cardiac fibrotic remodelling characterised by the phenotypic switching of cardiac fibroblasts (CFs) and collagen deposition. We tested the hypothesis that Wnt1-inducible signalling pathway protein-1 (WISP-1) promotes CFs’ phenotypic switch, type I collagen synthesis, and in vivo fibrotic remodelling. The treatment of human CFs (HCFs, n = 16) with WISP-1 (500 ng/mL) induced a phenotypic switch (α-smooth muscle actin-positive) and type I procollagen cleavage to an intermediate form of collagen (pC-collagen) in conditioned media after 24h, facilitating collagen maturation. WISP-1-induced collagen processing was mediated by Akt phosphorylation via integrin β1, and disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAMTS-2). WISP-1 wild-type (WISP-1+/+) mice and WISP-1 knockout (WISP-1−/−) mice (n = 5–7) were subcutaneously infused with angiotensin II (AngII, 1000 ng/kg/min) for 28 days. Immunohistochemistry revealed the deletion of WISP-1 attenuated type I collagen deposition in the coronary artery perivascular area compared to WISP-1+/+ mice after a 28-day AngII infusion, and therefore, the deletion of WISP-1 attenuated AngII-induced cardiac fibrosis in vivo. Collectively, our findings demonstrated WISP-1 is a critical mediator in cardiac fibrotic remodelling, by promoting CFs’ activation via the integrin β1-Akt signalling pathway, and induced collagen processing and maturation via ADAMTS-2. Thereby, the modulation of WISP-1 levels could provide potential therapeutic targets in clinical treatment.
- Open Access
- 27 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 5809
Pharmacological Inhibition of MMP-12 Exerts Protective Effects on Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice
Human abdominal aortic aneurysms (AAAs) are characterized by increased activity of matrix metalloproteinases (MMP), including MMP-12, alongside macrophage accumulation and elastin degradation, in conjunction with superimposed atherosclerosis. Previous genetic ablation studies have proposed contradictory roles for MMP-12 in AAA development. In this study, we aimed to elucidate if pharmacological inhibition of MMP-12 activity with a phosphinic peptide inhibitor protects from AAA formation and progression in angiotensin (Ang) II-infused Apoe−/− mice. Complimentary studies were conducted in a human ex vivo model of early aneurysm development. Administration of an MMP-12 inhibitor (RXP470.1) protected hypercholesterolemia Apoe−/− mice from Ang II-induced AAA formation and rupture-related death, associated with diminished medial thinning and elastin fragmentation alongside increased collagen deposition. Proteomic analyses confirmed a beneficial effect of MMP-12 inhibition on extracellular matrix remodeling proteins combined with inflammatory pathways. Furthermore, RXP470.1 treatment of mice with pre-existing AAAs exerted beneficial effects as observed through suppressed aortic dilation and rupture, medial thinning, and elastin destruction. Our findings indicate that pharmacological inhibition of MMP-12 activity retards AAA progression and improves survival in mice providing proof-of-concept evidence to motivate translational work for MMP-12 inhibitor therapy in humans.
- 27 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 5809
Open AccessPharmacological Inhibition of MMP-12 Exerts Protective Effects on Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice
Human abdominal aortic aneurysms (AAAs) are characterized by increased activity of matrix metalloproteinases (MMP), including MMP-12, alongside macrophage accumulation and elastin degradation, in conjunction with superimposed atherosclerosis. Previous genetic ablation studies have proposed contradictory roles for MMP-12 in AAA development. In this study, we aimed to elucidate if pharmacological inhibition of MMP-12 activity with a phosphinic peptide inhibitor protects from AAA formation and progression in angiotensin (Ang) II-infused Apoe−/− mice. Complimentary studies were conducted in a human ex vivo model of early aneurysm development. Administration of an MMP-12 inhibitor (RXP470.1) protected hypercholesterolemia Apoe−/− mice from Ang II-induced AAA formation and rupture-related death, associated with diminished medial thinning and elastin fragmentation alongside increased collagen deposition. Proteomic analyses confirmed a beneficial effect of MMP-12 inhibition on extracellular matrix remodeling proteins combined with inflammatory pathways. Furthermore, RXP470.1 treatment of mice with pre-existing AAAs exerted beneficial effects as observed through suppressed aortic dilation and rupture, medial thinning, and elastin destruction. Our findings indicate that pharmacological inhibition of MMP-12 activity retards AAA progression and improves survival in mice providing proof-of-concept evidence to motivate translational work for MMP-12 inhibitor therapy in humans.
- Open Access
- 30 December 2023
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 21 (4) , 785-792
Prevalence, prescription patterns, and quality of life of anaemia in adults with chronic renal disease
Introduction and aim. Anaemia is a chronic kidney disease (CKD) condition characterised by a decline in glomerular filtration rate (GFR) and impaired kidney function. The aim of this study was to assess the prevalence, prescribing patterns, and quality of life of anaemia in patients with chronic renal disease who were adults (>18 years of age) at a tertiary care hospital. Material and methods. Data on demographic characteristics, laboratory results, medication prescriptions, and quality of life assessments were collected. Statistical tests were performed to determine associations between anaemia prevalence and factors like age, gender, and CKD stage. The study included 132 patients, with a gender distribution of 89 men and 43 women. Results. The most frequently prescribed drugs are epoetin (15.06%), multivitamins (14.82%), iron (10.65%), folic acid (10.22%), calcium carbonate (8.17%), calcitriol (5.6%), and omeprazole (4.22%). The cardiovascular system, blood disorders, and blood-producing organs come after the gastrointestinal tract and metabolism in the first anatomical level of the ATC classification. Conclusion. It suggests hospital audits and recommendations for improved prescription practices. Further investigation into anaemia causes and drug class appropriateness is needed, and implementing improvements could potentially improve health outcomes.
- 30 December 2023
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 21 (4) , 785-792
Open AccessPrevalence, prescription patterns, and quality of life of anaemia in adults with chronic renal disease
Introduction and aim. Anaemia is a chronic kidney disease (CKD) condition characterised by a decline in glomerular filtration rate (GFR) and impaired kidney function. The aim of this study was to assess the prevalence, prescribing patterns, and quality of life of anaemia in patients with chronic renal disease who were adults (>18 years of age) at a tertiary care hospital. Material and methods. Data on demographic characteristics, laboratory results, medication prescriptions, and quality of life assessments were collected. Statistical tests were performed to determine associations between anaemia prevalence and factors like age, gender, and CKD stage. The study included 132 patients, with a gender distribution of 89 men and 43 women. Results. The most frequently prescribed drugs are epoetin (15.06%), multivitamins (14.82%), iron (10.65%), folic acid (10.22%), calcium carbonate (8.17%), calcitriol (5.6%), and omeprazole (4.22%). The cardiovascular system, blood disorders, and blood-producing organs come after the gastrointestinal tract and metabolism in the first anatomical level of the ATC classification. Conclusion. It suggests hospital audits and recommendations for improved prescription practices. Further investigation into anaemia causes and drug class appropriateness is needed, and implementing improvements could potentially improve health outcomes.
- Open Access
- 2 June 2021
- Published by Wiley in Journal of Cell Communication and Signaling
- Vol. 15 (3) , 421-432
Aneurysm severity is suppressed by deletion of CCN4
Patients with abdominal aortic aneurysms are frequently treated with high-risk surgery. A pharmaceutical treatment to reverse aneurysm progression could prevent the need for surgery and save both lives and healthcare resources. Since CCN4 regulates cell migration, proliferation and apoptosis, processes involved in aneurysm progression, it is a potential regulator of aneurysm progression. We investigated the role of CCN4 in a mouse aneurysm model, using apolipoprotein-E knockout (ApoE−/−) mice fed high fat diet and infused with Angiotensin II (AngII). Blood pressure was similarly elevated in CCN4−/−ApoE−/− mice and CCN4+/+ApoE−/− mice (controls) in response to AngII infusion. Deletion of CCN4 significantly reduced the number of ruptured aortae, both thoracic and abdominal aortic area, and aneurysm grade score, compared to controls. Additionally, the frequency of vessel wall remodelling and the number of elastic lamina breaks was significantly suppressed in CCN4−/−ApoE−/− mice compared to controls. Immunohistochemistry revealed a significantly lower proportion of macrophages, while the proportion of smooth muscle cells was not affected by the deletion of CCN4. There was also a reduction in both proliferation and apoptosis in CCN4−/−ApoE−/− mice compared to controls. In vitro studies showed that CCN4 significantly increased monocyte adhesion beyond that seen with TNFα and stimulated macrophage migration by more than threefold. In summary, absence of CCN4 reduced aneurysm severity and improved aortic integrity, which may be the result of reduced macrophage infiltration and cell apoptosis. Inhibition of CCN4 could offer a potential therapeutic approach for the treatment of aneurysms.
- 2 June 2021
- Published by Wiley in Journal of Cell Communication and Signaling
- Vol. 15 (3) , 421-432
Open AccessAneurysm severity is suppressed by deletion of CCN4
Patients with abdominal aortic aneurysms are frequently treated with high-risk surgery. A pharmaceutical treatment to reverse aneurysm progression could prevent the need for surgery and save both lives and healthcare resources. Since CCN4 regulates cell migration, proliferation and apoptosis, processes involved in aneurysm progression, it is a potential regulator of aneurysm progression. We investigated the role of CCN4 in a mouse aneurysm model, using apolipoprotein-E knockout (ApoE−/−) mice fed high fat diet and infused with Angiotensin II (AngII). Blood pressure was similarly elevated in CCN4−/−ApoE−/− mice and CCN4+/+ApoE−/− mice (controls) in response to AngII infusion. Deletion of CCN4 significantly reduced the number of ruptured aortae, both thoracic and abdominal aortic area, and aneurysm grade score, compared to controls. Additionally, the frequency of vessel wall remodelling and the number of elastic lamina breaks was significantly suppressed in CCN4−/−ApoE−/− mice compared to controls. Immunohistochemistry revealed a significantly lower proportion of macrophages, while the proportion of smooth muscle cells was not affected by the deletion of CCN4. There was also a reduction in both proliferation and apoptosis in CCN4−/−ApoE−/− mice compared to controls. In vitro studies showed that CCN4 significantly increased monocyte adhesion beyond that seen with TNFα and stimulated macrophage migration by more than threefold. In summary, absence of CCN4 reduced aneurysm severity and improved aortic integrity, which may be the result of reduced macrophage infiltration and cell apoptosis. Inhibition of CCN4 could offer a potential therapeutic approach for the treatment of aneurysms.